Therapeutic Asset Ratings
177 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
THIOGUANINE ANHYDROUS
T Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(64)
Zanubrutinib
High Grade B-Cell Lymphoma, Not Otherwise Specified
SWOG Cancer Research Network
P3
BB
(64)
Cyclophosphamide
Acute Leukemia of Ambiguous Lineage
SWOG Cancer Research Network
P2
BB
(64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Acute Leukemia
SWOG Cancer Research Network
P2
BB
(64)
PREDNISONE TABLETS
Acute Leukemia
SWOG Cancer Research Network
P2
BB
(64)
Tisagenlecleucel
Primary Mediastinal Large B Cell Lymphoma
SWOG Cancer Research Network
P2
BB
(64)
TRASTUZUMAB
ERBB2 Gene Amplification
SWOG Cancer Research Network
P2
BB
(64)
ETOPOSIDE
Acute Leukemia
SWOG Cancer Research Network
P2/3
BB
(64)
Inno-206
Acute Leukemia
SWOG Cancer Research Network
P2/3
BB
(64)
Calaspargase Pegol
T Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
B
(63)
ETOPOSIDE
B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
SWOG Cancer Research Network
P3
B
(63)
Trastuzumab Deruxtecan
HER2-positive Breast Cancer
SWOG Cancer Research Network
P3
B
(63)
(+)-VINCRISTINE
Richter Syndrome
SWOG Cancer Research Network
P3
B
(63)
DEXAMETHASONE
Acute Leukemia
SWOG Cancer Research Network
P2/3
B
(63)
Calcium folinate pentahydrate
T Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
B
(62)
Inno-206
B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
SWOG Cancer Research Network
P3
B
(62)
Ipilimumab
Clear Cell Renal Cell Carcinoma
SWOG Cancer Research Network
P3
B
(62)
Irinotecan Sucrosofate
Metastatic Pancreatic Cancer
SWOG Cancer Research Network
P3
B
(62)
PANITUMUMAB
Locally Advanced Pancreatic Adenocarcinoma
SWOG Cancer Research Network
P3
B
(62)
Recombinant Human Hyaluronidase
Richter Syndrome
SWOG Cancer Research Network
P3
B
(62)
Zanubrutinib
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
SWOG Cancer Research Network
P3
B
(62)
Cytosin-Arabinosid
Acute Leukemia of Ambiguous Lineage
SWOG Cancer Research Network
P2
B
(62)
METHOTREXATE
Acute Leukemia of Ambiguous Lineage
SWOG Cancer Research Network
P2
B
(62)
(+)-VINCRISTINE
Acute Leukemia
SWOG Cancer Research Network
P2/3
B
(62)
Axitinib
Clear Cell Renal Cell Carcinoma
SWOG Cancer Research Network
P3
B
(60)
Showing 76 to 100 of 177 assets
Previous
Page 4 of 8
Next